mercredi 13 juillet 2016

Onco Actu du 13 juillet 2016

NB : la publication quotidienne d'Onco Actu s'interrompt, elle reprendra à partir du lundi 25 juillet.

2.12 Etiologie - UV

Hidden red hair gene a skin cancer risk [BBC News]

Scientists closer to understanding why red hair genes increase skin cancer risk [The Guardian]

Skin cancer risk for freckly red-heads equivalent to 21 years in sun [Reuters]

4. Dépistage, diagnostic et pronostic

A ‘scientific deli slicer’ that offers pathologists a high-tech look at tumors [STAT]

4.11 Dép., diag. & prono. - Ovaire

Simplifying access to gene testing for women with ovarian cancer improves treatment choices and could save lives [The Institute of Cancer Research]

5.12.2 Immunothérapies - CAR-T

Juno Therapeutics to Resume JCAR015 Phase II ROCKET Trial [Juno Therapeutics]

Juno Therapeutics Re-Starts Cancer Trial After Deaths Put Study on Hold [Forbes]

FDA lets cancer trial resume after three patient deaths [STAT]

Shares of Juno Therapeutics jump after FDA removes clinical hold on cancer drug trial [Reuters]

5.2 Pharma

With Bugs As Drugs, Evelo CEO Plans Immune, Cancer Trials in 2017 [Xconomy]

5.2.2 Pharma - Fusions & Acquisitions

AstraZeneca mulling a $10-billion bid for Medivation [Pharmafile]

Sanofi Sees Cure for Cancer Woes in Moving West for Acquisitions [Bloomberg]

5.2.3 Pharma - économie

Merck to cut 360 R&D jobs, close one facility, and expand elsewhere [STAT]

6. Lutte contre les cancers

Are patients being told about opportunities to take part in research? [Cancer Research UK]

6.11 Patients

Unrealistic expectations may hinder blood cancer patients' care [Reuters]

6.5 Médecines alternatives

Quackademic medicine and acupressure at my alma mater [Respectful Insolence]

6.6 Publications

Another step towards the post-journal world [BMJ Blogs]

Watch out for cheats in citation game [Nature News & Comment]